Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2
Go back to Pfizer and BioNTech Announce Agreement with the United Kingdom for 30 Million Doses of mRNA-based Vaccine Candidate against SARS-CoV-2| (NASDAQ: BNTX) | Delayed: 100.87 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $100.87 | 52 Week High | $ | |||
| Open | $100.87 | 52 Week Low | $ | |||
| Day High | $100.87 | P/E | N/A | |||
| Day Low | $100.87 | EPS | $ | |||
| Volume | 3,984 | |||||
| Pfizer Inc. (NYSE: PFE) | Delayed: 27.93 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $27.93 | 52 Week High | $37.39 | |||
| Open | $27.93 | 52 Week Low | $28.25 | |||
| Day High | $27.93 | P/E | 16.93 | |||
| Day Low | $27.93 | EPS | $1.65 | |||
| Volume | 25,192 | |||||

